.Pharmacolibrary.Drugs.S_SensoryOrgans.S01B_AntiinflammatoryAgents.S01BA05_Triamcinolone.Triamcinolone .Pharmacolibrary.Drugs.S_SensoryOrgans.S01B_AntiinflammatoryAgents.S01BA05_Triamcinolone.Triamcinolone| name: | Triamcinolone |
| ATC code: | S01BA05 | route: | intravitreal |
| n-compartments | 1 |
Triamcinolone is a synthetic corticosteroid with potent anti-inflammatory, immunosuppressive, and anti-allergic properties. It is primarily used for the treatment of various ocular inflammatory conditions such as uveitis, allergic conjunctivitis, and post-surgical ocular inflammation. The drug, particularly triamcinolone acetonide, is approved and in clinical use today, especially as intraocular or periocular steroid injections.
Pharmacokinetic parameters after single intravitreal administration of triamcinolone acetonide in adult patients with macular edema.
Beer, PM, et al., & Miller, M (2003). Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110(4) 681–686. DOI:10.1016/S0161-6420(02)01969-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12689886
Dutra Medeiros, M, et al., & Nucci, P (2014). Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema. European endocrinology 10(2) 111–116. DOI:10.17925/EE.2014.10.02.111 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29872474
Audren, F, et al., & Bergmann, JF (2004). Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Investigative ophthalmology & visual science 45(10) 3435–3441. DOI:10.1167/iovs.03-1110 PUBMED:https://pubmed.ncbi.nlm.nih.gov/15452046